{"DataElement":{"publicId":"3113312","version":"1","preferredName":"Soft Tissue Sarcoma Pathologic N Stage","preferredDefinition":"Alphanumeric code to signify the extent of tumor involvement at the lymph nodes or N (Nodal) site(s)","longName":"SAR_PATH_N_STG","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2197710","version":"1","preferredName":"Sarcoma Pathologic N Stage","preferredDefinition":"information related to the pathologic N stage of a sarcoma.","longName":"SARCOMA_P_N","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2177012","version":"1","preferredName":"Sarcoma","preferredDefinition":"A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004","longName":"Sarcoma","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AD9-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFC4E03-AC2F-6E32-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-31","modifiedBy":"TAYLORT","dateModified":"2019-03-29","changeDescription":"3-29-19 Received permission from Brian Campbell to transfer DEC ownership from CTEP to NCI Standards; tmt.  Updated to use Property based on NCIt concepts","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3113309","version":"1","preferredName":"Soft Tissue Sarcoma Pathologic N Stage","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones._Caused by or altered by or manifesting disease or pathology_One criteria of the TNM staging system.  N refers to the extent of lymph node involvement.","longName":"SAR_PATH_N_STG","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N1","valueDescription":"Regional lymph node metastasis","ValueMeaning":{"publicId":"3113310","version":"1","preferredName":"Regional lymph node metastasis","longName":"3113310","preferredDefinition":"N1 Regional lymph node metastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899DCB78-F701-1174-E040-BB89AD430323","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899DCB78-F71A-1174-E040-BB89AD430323","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","deletedIndicator":"No"},{"value":"NX","valueDescription":"NX Stage Finding","ValueMeaning":{"publicId":"2580837","version":"1","preferredName":"NX Stage Finding","longName":"2580837","preferredDefinition":"Status of regional lymph nodes cannot be assessed in accordance with TNM classification system guidelines. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08D2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-13","modifiedBy":"ONEDATA","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899DCB78-F724-1174-E040-BB89AD430323","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","deletedIndicator":"No"},{"value":"N0","valueDescription":"N0 Stage Finding","ValueMeaning":{"publicId":"2580833","version":"1","preferredName":"N0 Stage Finding","longName":"2580833","preferredDefinition":"No evidence of regional lymph node metastasis, in accordance with TNM classification system guidelines. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08CE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-13","modifiedBy":"ONEDATA","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899DCB78-F72F-1174-E040-BB89AD430323","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3113308","version":"1","preferredName":"Soft Tissue Sarcoma Pathologic N Stage Stage","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.:Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C9306:C25610:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899DCB78-F6DC-1174-E040-BB89AD430323","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"899DCB78-F6ED-1174-E040-BB89AD430323","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812734","version":"1","longName":"U Washington New CDEs","context":"NCIP"},{"publicId":"3113297","version":"1","longName":"FMISO Soft Tissue Sarcoma Study","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899DCB78-F73A-1174-E040-BB89AD430323","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated for UWMC Sarcoma Trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}